North America Digital Breast Tomosynthesis (DBT) Equipment Market

North America Digital Breast Tomosynthesis (DBT) Equipment Market Size

The North America digital breast tomosynthesis (DBT) equipment market was valued at USD 614.5 million in 2024, is estimated to reach USD 704 million in 2025, and is projected to reach USD 2,079 million by 2033, growing at a CAGR of 14.50% from 2024 to 2033.

MARKET DRIVERS

Rising Breast Cancer Incidence and Imaging Technology Advancements Fuel Market Growth

Y-O-Y growth in the incidence of breast cancer in North American countries is predicted to drive market growth. Breast cancer is the most common and regular kind of cancer among women, and nearly 2.1 million people have breast cancer yearly. Advancements in technology for enhancing new and inventive imaging products are stimulating the market. Every 1 in 8women, i.e., 13%, will be identified with breast cancer in their lifetime, and 1 in 39 women means 3% die of breast cancer in the US, in 2019, according to the American Cancer Society. The rising incidence rate of cancer in developing countries with a mounting lifespan and growing obtainment of unhealthy lifestyles escalates the market. Huge vital players are paying their attention to acquiring partnership and collaboration strategies to enlarge their product portfolio. Planmed Oy combined with Disior Oy for integrating Disior's orthopedic analysis software along with Planmed's high-tech cone-beam Computed Tomography (CBCT) scanner, Planned Verity in 2018 November.

MARKET RESTRAINTS

High Costs and Limited Reimbursement Policies Restrain DBT Equipment Market

Strict training requirements for radiologists and technologists, scarcity of reimbursement policies from government and private organizations hamper the region's DBT equipment growth. The increasing cost of the DBT treatment and the maintenance and installation of these devices restrict the market.

REPORT COVERAGE

REGIONAL ANALYSIS

North America was the leading region in the global DBT equipment market in 2024. It will retain its position till 2033. The US accounted for the largest market share. Growing breast cancer across the world and a surge in tomosynthesis usage propel the growth in the market. Massive demand for innovative products, increasing screening acquisition, and experienced healthcare professionals are adding fuel to the region's market.

The United States DBT Equipment market is forecasted to account for the largest share in the North American market due to increasing awareness regarding the devices' usage, and a high determining rate is driving the market. Around 627,000 women lost their lives due to breast cancer, which is nearly 15% of women's cancer deaths.

Canada is witnessing rapid growth in the DBT equipment market because of the existence of highly enhanced infrastructure, and stimulating healthcare expenditure in the region is to accelerate the development of DBT in North America.

KEY MARKET PLAYERS

Promising Companies leading the North America Digital Breast Tomosynthesis (DBT) Equipment Market Profiled in the Report are Hologic Inc., Siemens Healthineers, and Fujifilm Corporation. Other players in the market include GE Healthcare, Internazionale Medico Scientifica S.r.l., and Planmed Oy.

MARKET SEGMENTATION

This research report on the North America Digital Breast Tomosynthesis (DBT) Equipment Market has been segmented and sub-segmented into the following categories

By Product

• 3-D Upgradation
• DBT Equipment

By End User

• Hospitals
• Diagnostic centers

By Country

• The United States
• Canada
• Rest of North America